NOD1/RIP2通路通过微质M2极化促进质瘤的进展.
Yuxue Luan1, Miao Yu1, Haimo Zhang1
1School of Medical Imaging, Shandong Second Medical University, Weifang, China.
CNS neuroscience & therapeutics
|December 9, 2025
概括
核结合的寡合化域含有蛋白1 (NOD1) /受体相互作用蛋白2 (RIP2) 途径通过增强M2微质极化促进质瘤的进展. 抑制这种途径可以减少瘤的生长,改善预后.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 质瘤是一种有侵略性的中枢神经系统恶性瘤,预后不佳.
- NOD1/RIP2通路影响炎症反应和微质极化.
- M2微质极化促进瘤微环境中的质瘤生长.
研究的目的:
- 研究NOD1/RIP2途径在质瘤进展中的作用.
- 为了确定NOD1/RIP2信号是否影响微质M2极化.
- 评估NOD1作为质瘤的预后标志物.
主要方法:
- 对质瘤组织中NOD1表达的生物信息学分析.
- 在体外研究中,使用用NOD1抑制剂ML130.0.治疗的质瘤细胞和微质细胞进行了研究.
- 在体内实验中使用老鼠质瘤模型进行实验.
- 对细胞增殖,迁移,入侵和M2极化标记物的评估 (Arg1,CD206).
主要成果:
- NOD1表达在质瘤组织中升高,与较高的瘤等级相关.
- NOD1抑制 (ML130) 抑制了质瘤细胞的增殖,迁移和入侵.
- ML130治疗减少了微质中的M2极化标志物,并在体内抑制了瘤生长.
- NOD1表达与rADC值负相关,表明它是潜在的成像生物标志物.
结论:
- NOD1是质瘤等级和患者预后的重要预测因子.
- NOD1/RIP2通路通过促进M2微质极化驱动质瘤的进展.
- 准NOD1/RIP2通路为质瘤提供了一个潜在的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


